It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
PBH’s FA Score shows that 2 FA rating(s) are green whilePROC’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
PBH’s TA Score shows that 5 TA indicator(s) are bullish while PROC’s TA Score has 6 bullish TA indicator(s).
PBH (@Pharmaceuticals: Other) experienced а -5.70% price change this week, while PROC (@Pharmaceuticals: Other) price change was +32.74% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.75%. For the same industry, the average monthly price growth was +1.64%, and the average quarterly price growth was -9.20%.
PBH is expected to report earnings on Feb 06, 2025.
PROC is expected to report earnings on Feb 26, 2025.
Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
PBH | PROC | PBH / PROC | |
Capitalization | 3.6B | 327M | 1,102% |
EBITDA | 10.8M | 137M | 8% |
Gain YTD | 28.700 | -26.290 | -109% |
P/E Ratio | 14.90 | 5.71 | 261% |
Revenue | 1.13B | 406M | 279% |
Total Cash | 63.6M | 20M | 318% |
Total Debt | 1.21B | 288M | 422% |
PBH | ||
---|---|---|
OUTLOOK RATING 1..100 | 64 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 76 Overvalued | |
PROFIT vs RISK RATING 1..100 | 8 | |
SMR RATING 1..100 | 60 | |
PRICE GROWTH RATING 1..100 | 46 | |
P/E GROWTH RATING 1..100 | 30 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PBH | PROC | |
---|---|---|
RSI ODDS (%) | 1 day ago78% | 1 day ago38% |
Stochastic ODDS (%) | 1 day ago72% | 1 day ago54% |
Momentum ODDS (%) | 1 day ago62% | 1 day ago52% |
MACD ODDS (%) | 1 day ago51% | 1 day ago57% |
TrendWeek ODDS (%) | 1 day ago54% | 1 day ago44% |
TrendMonth ODDS (%) | 1 day ago47% | 1 day ago41% |
Advances ODDS (%) | 18 days ago60% | 3 days ago52% |
Declines ODDS (%) | 1 day ago53% | N/A |
BollingerBands ODDS (%) | 1 day ago76% | 1 day ago47% |
Aroon ODDS (%) | 1 day ago56% | 1 day ago45% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
GEGCX | 13.42 | -0.23 | -1.68% |
abrdn Emerging Markets C | |||
AWSHX | 63.91 | -1.88 | -2.86% |
American Funds Washington Mutual A | |||
SBRAX | 19.58 | -0.62 | -3.07% |
Segall Bryant & Hamill All Cap Ret | |||
BRWUX | 25.22 | -0.85 | -3.26% |
MFS Blended Research Growth Eq R4 | |||
HRSRX | 72.64 | -3.41 | -4.48% |
Hood River Small-Cap Growth Investor |